These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1602618)

  • 1. [Essential thrombocythemia that transformed to myelofibrosis after three years].
    Akimoto Y; Ishiyama T; Sano M; Ueno H; Nakamaki T; Hino K; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1992 Apr; 33(4):520-4. PubMed ID: 1602618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis].
    Uesugi Y; Toba K; Nikkuni K; Fuse I; Koike T; Shibata A
    Rinsho Ketsueki; 1995 Oct; 36(10):1210-6. PubMed ID: 8531333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Essential thrombocythemia transformed to myelofibrosis with myeloid metaplasia after seven years].
    Yamagishi M; Yamamoto T; Ohmori M
    Rinsho Ketsueki; 1991 Mar; 32(3):239-43. PubMed ID: 2041165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Essential thrombocythemia transformed to acute myeloblastic leukemia].
    Okuda M; Shishido T; Sato A; Nagai T; Sugawara T; Kameoka J; Kaneda K; Meguro K; Fukuhara O; Sakurai T
    Rinsho Ketsueki; 1990 Oct; 31(10):1689-93. PubMed ID: 2255058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic transformation of essential thrombocythemia. A case report.
    Honma K; Nemoto K; Ohnishi Y; Kimura K
    Acta Pathol Jpn; 1989 Oct; 39(10):670-6. PubMed ID: 2589080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutrophilic myelofibrosis; a case report].
    Okamoto R; Harano H; Tamura T; Tanabe J; Fujita H; Fukawa H; Kanamori H; Matsuźaki M; Motomura S; Mohri H
    Rinsho Ketsueki; 1993 Aug; 34(8):957-61. PubMed ID: 8411651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
    Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
    Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of post-essential thrombocythemia myelofibrosis with severe osteosclerosis].
    Lee KK; Cho HI; Chi HS; Kim DY; Chae SL; Huh HJ
    Korean J Lab Med; 2010 Apr; 30(2):122-5. PubMed ID: 20445328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL; Ortiz-Hidalgo C
    Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis.
    Geissler K; Jäger E; Gisslinger B; Thiele J; Schwarzinger I; Gisslinger H
    Am J Hematol; 2014 Dec; 89(12):1157-8. PubMed ID: 25112775
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
    Marcinek J; Plank L; Szépe P; Balhárek T
    Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
    Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary myelofibrosis transforming into multiple subcutaneous monoblastoma--a case report].
    Hamamoto K; Taniguchi H; Ohga S; Nagano T; Kishimoto Y; Kitajima H; Fujimoto M; Kimura T; Fujitake H; Yasunaga K
    Rinsho Ketsueki; 1991 Nov; 32(11):1481-5. PubMed ID: 1758057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis.
    Ponce CC; de Lourdes F Chauffaille M; Ihara SS; Silva MR
    Med Oncol; 2012 Dec; 29(4):2337-44. PubMed ID: 22200991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.